632 related articles for article (PubMed ID: 24467635)
1. Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: diet or supplementation for metabolic syndrome prevention?
Peluso I; Romanelli L; Palmery M
Int J Food Sci Nutr; 2014 May; 65(3):259-67. PubMed ID: 24467635
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
Serban DE
Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
[TBL] [Abstract][Full Text] [Related]
3. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
5. Nutraceuticals and prevention of atherosclerosis: focus on omega-3 polyunsaturated fatty acids and Mediterranean diet polyphenols.
Massaro M; Scoditti E; Carluccio MA; De Caterina R
Cardiovasc Ther; 2010 Aug; 28(4):e13-9. PubMed ID: 20633019
[TBL] [Abstract][Full Text] [Related]
6. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
8. Obesity, Metabolic Syndrome, and Dietary Therapeutical Approaches with a Special Focus on Nutraceuticals (Polyphenols): A Mini-Review.
Ríos-Hoyo A; Cortés MJ; Ríos-Ontiveros H; Meaney E; Ceballos G; Gutiérrez-Salmeán G
Int J Vitam Nutr Res; 2014; 84(3-4):113-23. PubMed ID: 26098475
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment.
De Filippis A; Ullah H; Baldi A; Dacrema M; Esposito C; Garzarella EU; Santarcangelo C; Tantipongpiradet A; Daglia M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668581
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
Li DY; Yang M; Edwards S; Ye SQ
JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
[TBL] [Abstract][Full Text] [Related]
11. Interactions of probiotics and prebiotics with the gut microbiota.
Ballan R; Battistini C; Xavier-Santos D; Saad SMI
Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
[TBL] [Abstract][Full Text] [Related]
12. Nutritional Management of Metabolic Endotoxemia: A Clinical Review.
Brown BI
Altern Ther Health Med; 2017 Jul; 23(4):42-54. PubMed ID: 28646814
[TBL] [Abstract][Full Text] [Related]
13. Influence of functional food components on gut health.
Wan MLY; Ling KH; El-Nezami H; Wang MF
Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
[TBL] [Abstract][Full Text] [Related]
14. Designing future prebiotic fiber to target metabolic syndrome.
Jakobsdottir G; Nyman M; Fåk F
Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
[TBL] [Abstract][Full Text] [Related]
15. Interactions of gut microbiota with functional food components and nutraceuticals.
Laparra JM; Sanz Y
Pharmacol Res; 2010 Mar; 61(3):219-25. PubMed ID: 19914380
[TBL] [Abstract][Full Text] [Related]
16. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
[TBL] [Abstract][Full Text] [Related]
17. [Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].
Shikh EV; Nikolaeva NB; Molchanova NB; Elizarova EV
Vopr Pitan; 2023; 92(6):107-119. PubMed ID: 38198424
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome.
Stoidis CN; Misiakos EP; Patapis P; Fotiadis CI; Spyropoulos BG
Nutr Res Rev; 2011 Jun; 24(1):21-30. PubMed ID: 20961485
[TBL] [Abstract][Full Text] [Related]
19. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.
Duda-Chodak A; Tarko T; Satora P; Sroka P
Eur J Nutr; 2015 Apr; 54(3):325-41. PubMed ID: 25672526
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic syndrome and intestinal microflora: what overall?].
Plotnikova EIu; Krasnov OA
Eksp Klin Gastroenterol; 2014; (12):64-73. PubMed ID: 26058115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
